Status:
COMPLETED
Evaluation of Factors II, VII, IX, X, and Proteins C and S, Following High-dose Vitamin K Supplementation
Lead Sponsor:
Stephan Moll, MD
Conditions:
Thrombosis
Eligibility:
MALE
20-85 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate factor levels of the pro coagulant factors II, VII, IX, X, and the anticoagulant factors protein C and S in healthy volunteers during the intake of elevated le...
Detailed Description
1. Recruit 8 male healthy individuals with no prior history of arterial or venous thrombosis (2 each from each of the following age ranges: 20-34, 35-49, 50-64, \>65). 2. Visit 1: Measure baseline act...
Eligibility Criteria
Inclusion
- Healthy adult male
Exclusion
- prior history of arterial or venous thrombosis
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01143831
Start Date
November 1 2009
End Date
March 1 2012
Last Update
June 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599